Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice. 2003

B Y H Lam, and A C Y Lo, and X Sun, and H W Luo, and S K Chung, and N J Sucher
Department of Biology, Molecular Neuroscience Center and Biotechnology Research Institute, Hong Kong University of Science & Technology, Kowloon, Hong Kong SAR, China.

Tanshinones are the major lipid soluble pharmacological constituents of Danshen, the dried roots of Salvia miltiorrhiza Bunge (Labiatae), a well known traditional Chinese medicine used for the treatment of cerebrovascular diseases including stroke. Potential neuroprotective effects of tanshinones IIA (TsIIA) and IIB (TsIIB) were examined in adult mice subjected to transient focal cerebral ischemia caused by middle cerebral artery occlusion (MCAo). Our results revealed that TsIIA (16 mg/kg) readily penetrated the blood brain barrier reaching a peak concentration of 0.41 nmol/g brain wet weight 60 minutes after intraperitoneal injection and decreased slowly over several hours. Twenty-four hours after middle cerebral artery occlusion, brain infarct volume was reduced by 30% and 37% following treatment with TsIIA and TsIIB, respectively. The reduction in brain infarct volume was accompanied by a significant decrease in the observed neurological deficit. Tanshinones or other structurally related compounds may have potential for further development as neuroprotective drugs.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008297 Male Males
D008517 Phytotherapy Use of plants or herbs to treat diseases or to alleviate pain. Herb Therapy,Herbal Therapy
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010616 Phenanthrenes POLYCYCLIC AROMATIC HYDROCARBONS composed of three fused BENZENE rings.
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D004365 Drugs, Chinese Herbal Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China. Chinese Herbal Drugs,Plant Extracts, Chinese,Chinese Drugs, Plant,Chinese Plant Extracts,Extracts, Chinese Plant,Herbal Drugs, Chinese
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

B Y H Lam, and A C Y Lo, and X Sun, and H W Luo, and S K Chung, and N J Sucher
January 2012, Journal of neurosurgical anesthesiology,
B Y H Lam, and A C Y Lo, and X Sun, and H W Luo, and S K Chung, and N J Sucher
August 2012, Molecules (Basel, Switzerland),
B Y H Lam, and A C Y Lo, and X Sun, and H W Luo, and S K Chung, and N J Sucher
January 2017, PloS one,
B Y H Lam, and A C Y Lo, and X Sun, and H W Luo, and S K Chung, and N J Sucher
April 2016, Molecular medicine reports,
B Y H Lam, and A C Y Lo, and X Sun, and H W Luo, and S K Chung, and N J Sucher
January 2019, Evidence-based complementary and alternative medicine : eCAM,
B Y H Lam, and A C Y Lo, and X Sun, and H W Luo, and S K Chung, and N J Sucher
February 2009, Neuroscience letters,
B Y H Lam, and A C Y Lo, and X Sun, and H W Luo, and S K Chung, and N J Sucher
May 2009, Phytotherapy research : PTR,
B Y H Lam, and A C Y Lo, and X Sun, and H W Luo, and S K Chung, and N J Sucher
December 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
B Y H Lam, and A C Y Lo, and X Sun, and H W Luo, and S K Chung, and N J Sucher
June 2008, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials,
B Y H Lam, and A C Y Lo, and X Sun, and H W Luo, and S K Chung, and N J Sucher
September 2008, Brain research,
Copied contents to your clipboard!